Explore

Trendline Trendline
Eli Lilly, Bristol Myers Squibb, and Incyte Advance AI Integration in Drug Development

Eli Lilly, Bristol Myers Squibb, and Incyte Advance AI Integration in Drug Development

Eli Lilly, Bristol Myers Squibb, and Incyte Advance AI Integration in Drug Development
Trendline Trendline
Bristol Myers Squibb Partners with Anthropic to Deploy AI Platform Claude

Bristol Myers Squibb Partners with Anthropic to Deploy AI Platform Claude

Bristol Myers Squibb Partners with Anthropic to Deploy AI Platform Claude
Trendline Trendline
Bristol Myers Squibb Partners with Anthropic to Enhance AI Capabilities Across Global Operations

Bristol Myers Squibb Partners with Anthropic to Enhance AI Capabilities Across Global Operations

Bristol Myers Squibb Partners with Anthropic to Enhance AI Capabilities Across Global Operations
Trendline Trendline
Collaborative Drug Discovery and Eli Lilly Partner to Boost Biotech Innovation

Collaborative Drug Discovery and Eli Lilly Partner to Boost Biotech Innovation

Collaborative Drug Discovery and Eli Lilly Partner to Boost Biotech Innovation
Trendline Trendline
Incyte and Genesis Expand AI Collaboration to Boost Drug Discovery

Incyte and Genesis Expand AI Collaboration to Boost Drug Discovery

Incyte and Genesis Expand AI Collaboration to Boost Drug Discovery
Trendline Trendline
Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation

Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation

Collaborative Drug Discovery Partners with Eli Lilly to Enhance Biotech Innovation
Trendline Trendline
Anthropic Projects $10.9 Billion Revenue in Q2, Aiming for First Profitable Quarter

Anthropic Projects $10.9 Billion Revenue in Q2, Aiming for First Profitable Quarter

Anthropic Projects $10.9 Billion Revenue in Q2, Aiming for First Profitable Quarter
Trendline Trendline
Incyte and Edison Scientific Collaborate to Enhance Drug Development with AI

Incyte and Edison Scientific Collaborate to Enhance Drug Development with AI

Incyte and Edison Scientific Collaborate to Enhance Drug Development with AI
Trendline Trendline
Anthropic Hires OpenAI Co-Founder Andrej Karpathy to Boost AI Research Capabilities

Anthropic Hires OpenAI Co-Founder Andrej Karpathy to Boost AI Research Capabilities

Anthropic Hires OpenAI Co-Founder Andrej Karpathy to Boost AI Research Capabilities
Trendline Trendline
OpenBind Introduces AI Model to Revolutionize Drug Discovery

OpenBind Introduces AI Model to Revolutionize Drug Discovery

OpenBind Introduces AI Model to Revolutionize Drug Discovery
Trendline Trendline
Anthropic Acquires Stainless to Enhance AI Infrastructure

Anthropic Acquires Stainless to Enhance AI Infrastructure

Anthropic Acquires Stainless to Enhance AI Infrastructure
Trendline Trendline
SandboxAQ Integrates Drug Discovery Models into Claude for Enhanced Accessibility

SandboxAQ Integrates Drug Discovery Models into Claude for Enhanced Accessibility

SandboxAQ Integrates Drug Discovery Models into Claude for Enhanced Accessibility